The multidisciplinary team approach experience in the single institute of breast cancer patients: impact on disease-free survival

Authors

  • Amada Meechaicharoenying Faculty of Medicine, Thammasat University
  • Patcharaporn Dejburum Epidemiology Division, Mahasarakham Hospital
  • Panuch Eiamprapaporn คณะแพทยศาสตร์ มหาวิทยาลัยธรรมศาสตร์

Keywords:

multidisciplinary team (MDT), breast cancer, disease-free survival, retrospective analysis, Thailand

Abstract

Background: Breast cancer is a significant health concern in Thailand, and the multidisciplinary team (MDT) approach is widely regarded as a strategy to improve cancer care outcomes. This study aims to evaluate the impact of MDT care on disease-free survival (DFS) in patients treated at a single institution.

Methods: This retrospective review analyzed 677 breast cancer cases treated at Thammasat Hospital from 2012 to 2021. The study compared disease-free survival (DFS) between patients managed with a multidisciplinary team (MDT) approach (n=394) and those managed without MDT involvement (n=283). Survival outcomes were assessed using Kaplan-Meier methods and Cox regression analysis.

Results: The mean disease-free survival (DFS) was 10.14 years in the MDT group, compared to 10.09 years in the non-MDT group, with no statistically significant difference observed across the 0–11.5 years follow-up period (HR: 1.061, 95% CI: 0.653–1.726, p = 0.810). However, when follow-up extended beyond 5 years, the MDT group demonstrated superior DFS compared to the non-MDT group. Significant predisposing factors influencing DFS in the MDT group included ECOG performance status, cancer staging, receipt of radiotherapy, and hormonal therapy.

Conclusion: Although MDT care does not statistically improve DFS (Disease-Free Survival), there is an observed trend suggesting a survival benefit. Furthermore, significant factors affecting DFS in the MDT group included patients' ECOG performance status, cancer staging, receipt of radiotherapy, and hormonal therapy.

References

World Health Organization. Breast cancer [Internet]. Geneva: World Health Organization; 2023 [cited 2023 Oct 29]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer

National Cancer Prevention and Control Plan Committee, Department of Medical Services, Ministry of Public Health. National Cancer Prevention and Control Plan (2018–2022). Bangkok: Agricultural Cooperative Federation of Thailand Printing House; 2018.

Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387–97. doi: 10.7150/ijbs.21635.

Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin. 1991;41(3):146–65. doi: 10.3322/canjclin.41.3.146.

National Health Security Office. Mammography and ultrasound breast cancer screening to be accessible for Thai women with high risk [Internet]. Bangkok: National Health Security Office; 2024 [cited 2025 Jan 27]. Available from: https://eng.nhso.go.th/view/1/DescriptionNews/Mammography-and-ultrasound-breast-cancer-screening-to-be-accessible-for-Thai-women-with-high-risk/592/EN-US

National Cancer Institute. Breast cancer treatment (PDQ®) – patient version [Internet]. Bethesda (MD): National Cancer Institute; 2023 [cited 2025 Jan 27]. Available from: https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

Lamb B, Green JSA, Vincent C, Sevdalis N. Decision making in surgical oncology. Surg Oncol. 2011;20(3):163–8. doi: 10.1016/j.suronc.2010.07.007.

Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012;344:e2718.

Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Glob Oncol. 2018; 4:1–16.

Kang SY, Kim YS, Kim Z, Kim HY, Lee SK, Jung KW, et al. Breast cancer statistics in Korea in 2017: data from a breast cancer registry. J Breast Cancer. 2020;23(2):115–28.

Scott B. Multidisciplinary team approach in cancer care: a review of the latest advancements. Oncol. 2021;1–13.

Rogers MJ, Matheson L, Garrard B, Richards J, Lankshear A, Ramirez AJ. Comparison of outcomes for cancer patients discussed and not discussed at a multidisciplinary meeting. Public Health. 2017; 149:74–80.

Tsai CH, Hsieh HF, Lai TW, Chen FY, Chen SC, Chen SH. Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: a national matched cohort study. Breast. 2020; 53:68–76.

Lu J, Jiang Y, Qian M, Chen Z, He S, Cao Y, et al. The improved effects of a multidisciplinary team on the survival of breast cancer patients: experiences from China. Int J Environ Res Public Health. 2020;17(1):277.

Yang X, Huang J, Zhu X, Chen Y, Chen L, Wu J, et al. Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: an analysis of 4,501 consecutive patients. Breast. 2020; 52:135–45.

Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012; 344:e2718.

Tsai CH, Hsieh HF, Lai TW, Chen FY, Chen SC, Chen SH. Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: a national matched cohort study. Breast. 2020; 53:68–76.

Pangarsa EA, Rizky D, Tandarto K, Setiawan B, Santosa D, Hadiyanto JN, et al. The effect of multidisciplinary team on survival rates of women with breast cancer: a systematic review and meta-analysis.

Akram Y, Shahpar H. Determining prognostic factors of disease-free survival in breast cancer using censored quantile regression. Breast Cancer (Auckl). 2022; 16:1–6.

David R, Judy-Anne W, Wedad M, Harriette J, David M, Edward B, et al. Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Ann Surg Oncol. 2000;7(5):416–26.

Brandão M, Guisseve A, Bata G, Gudo R, Peters S, Egger M, et al. Survival impact and cost-effectiveness of a multidisciplinary tumor board for breast cancer in Mozambique, Sub-Saharan Africa. Oncologist. 2021;26(8):e996–e1008.

Downloads

Published

2025-11-13

How to Cite

1.
Meechaicharoenying A, Dejburum P, Eiamprapaporn P. The multidisciplinary team approach experience in the single institute of breast cancer patients: impact on disease-free survival. TUHJ [internet]. 2025 Nov. 13 [cited 2026 Feb. 6];10(3):91-106. available from: https://he02.tci-thaijo.org/index.php/TUHJ/article/view/274038

Issue

Section

บทความวิจัย